2m 2m 2m 2m 2m 2m 2m
UROGEN PHARMA (URGN)
NASDAQ
$39.76+$0.25 (+0.63%)
Price as of Jul 14, 2026 4:40 AM EDT- $1.8BMarket Cap
- 172.67%1-Year Change
- BiotechnologyIndustry
UROGEN PHARMA (URGN)
$39.76+$0.25 (+0.63%)
Earnings Score
Valuation | URGN | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | -0 | ||
Low Earnings Volatility | 1 |
Momentum Score
Valuation | URGN | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 46.60% | ||
12-Month Momentum | 96.63% | ||
3-Month Risk Adjusted Momentum | 163.38% | ||
12-Month Risk Adjusted Momentum | 147.27% |
True Yield
Valuation | URGN | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -15.36% |
Financial Health Score
Valuation | URGN | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 4 |